Burden of Clostridium difficile infection in the United States
- PMID: 25714160
- PMCID: PMC10966662
- DOI: 10.1056/NEJMoa1408913
Burden of Clostridium difficile infection in the United States
Abstract
Background: The magnitude and scope of Clostridium difficile infection in the United States continue to evolve.
Methods: In 2011, we performed active population- and laboratory-based surveillance across 10 geographic areas in the United States to identify cases of C. difficile infection (stool specimens positive for C. difficile on either toxin or molecular assay in residents ≥ 1 year of age). Cases were classified as community-associated or health care-associated. In a sample of cases of C. difficile infection, specimens were cultured and isolates underwent molecular typing. We used regression models to calculate estimates of national incidence and total number of infections, first recurrences, and deaths within 30 days after the diagnosis of C. difficile infection.
Results: A total of 15,461 cases of C. difficile infection were identified in the 10 geographic areas; 65.8% were health care-associated, but only 24.2% had onset during hospitalization. After adjustment for predictors of disease incidence, the estimated number of incident C. difficile infections in the United States was 453,000 (95% confidence interval [CI], 397,100 to 508,500). The incidence was estimated to be higher among females (rate ratio, 1.26; 95% CI, 1.25 to 1.27), whites (rate ratio, 1.72; 95% CI, 1.56 to 2.0), and persons 65 years of age or older (rate ratio, 8.65; 95% CI, 8.16 to 9.31). The estimated number of first recurrences of C. difficile infection was 83,000 (95% CI, 57,000 to 108,900), and the estimated number of deaths was 29,300 (95% CI, 16,500 to 42,100). The North American pulsed-field gel electrophoresis type 1 (NAP1) strain was more prevalent among health care-associated infections than among community-associated infections (30.7% vs. 18.8%, P<0.001).
Conclusions: C. difficile was responsible for almost half a million infections and was associated with approximately 29,000 deaths in 2011. (Funded by the Centers for Disease Control and Prevention.).
Figures

Comment in
-
Burden of Clostridium difficile infection in the United States.N Engl J Med. 2015 Jun 11;372(24):2369-70. doi: 10.1056/NEJMc1505190. N Engl J Med. 2015. PMID: 26061850 Free PMC article. No abstract available.
-
Burden of Clostridium difficile infection in the United States.N Engl J Med. 2015 Jun 11;372(24):2368. doi: 10.1056/NEJMc1505190. N Engl J Med. 2015. PMID: 26061851 No abstract available.
-
Burden of Clostridium difficile infection in the United States.N Engl J Med. 2015 Jun 11;372(24):2368-9. doi: 10.1056/NEJMc1505190. N Engl J Med. 2015. PMID: 26061852 No abstract available.
-
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota.Ann Intern Med. 2015 Sep 15;163(6):487-8. doi: 10.7326/L15-5139. Ann Intern Med. 2015. PMID: 26370022 No abstract available.
References
-
- McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene–variant strain of Clostridium difficile. N Engl J Med 2005;353:2433–41. - PubMed
-
- Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile–associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442–9. [Erratum, N Engl J Med 2006;354:2200.] - PubMed
-
- Healthcare Cost and Utilization Project. HCUP Projections: Clostridium difficile infection 2011 to 2012. Report # 2012–01 (http://www.hcup-us.ahrq.gov/reports/projections/CDI_Regional_projections...).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical